Lotagen injector sol. ad us.vet. 14,4 mg/ml šķīdums ievadīšanai dzemdē govīm un sivēnmātēm
Lotagen injector sol. ad us.vet. 14,4 mg/ml šķīdums ievadīšanai dzemdē govīm un sivēnmātēm
Authorised
- Policresulen
Product identification
Medicine name:
Lotagen injector sol. ad us.vet. 14,4 mg/ml šķīdums ievadīšanai dzemdē govīm un sivēnmātēm
Active substance:
- Policresulen
Target species:
-
Cattle (cow)
-
Pig (sow)
Route of administration:
-
Intrauterine use
Product details
Active substance and strength:
-
Policresulen2.16gram(s)1.00Container
Pharmaceutical form:
-
Intrauterine solution
Withdrawal period by route of administration:
-
Intrauterine use
-
Cattle (cow)
-
Meat and offal0day
-
-
Pig (sow)
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG51AD02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Package description:
- Available only in Latvian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/01/1364
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 21/03/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 21/03/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 21/03/2024
How useful was this page?: